APA citiranje

Chen, D., Chen, Q., Qin, X., Tong, P., Peng, L., Zhang, T., & Xia, C. (2023). Development and evolution of human glutaminyl cyclase inhibitors (QCIs): An alternative promising approach for disease-modifying treatment of Alzheimer's disease. Frontiers Media S.A.

Chicago Style (17th ed.) Citation

Chen, Daoyuan, Qingxiu Chen, Xiaofei Qin, Peipei Tong, Liping Peng, Tao Zhang, and Chunli Xia. Development and Evolution of Human Glutaminyl Cyclase Inhibitors (QCIs): An Alternative Promising Approach for Disease-modifying Treatment of Alzheimer's Disease. Frontiers Media S.A, 2023.

MLA citiranje

Chen, Daoyuan, et al. Development and Evolution of Human Glutaminyl Cyclase Inhibitors (QCIs): An Alternative Promising Approach for Disease-modifying Treatment of Alzheimer's Disease. Frontiers Media S.A, 2023.